Podcasts about Endocrine surgery

In this episode, we dive into the rapidly evolving world of ambient listening AI in healthcare. From outpatient clinics to inpatient wards and operating rooms, this technology is reshaping how care is delivered, documented, and experienced. We explore how ambient listening AI is improving clinic flow by streamlining documentation and reducing interruptions, allowing clinicians to stay more present with their patients. The technology is increasingly adaptive to individual provider styles, learning preferences and workflows to deliver more personalized support. Plus, we share practical tips for new users to get the most out of their ambient listening AI systems from day one. Join us as we hear from experts on the front lines and debate the future of ambient listening AI in medicine—where the walls really do have ears, but for all the right reasons. Host:  - Nicole Petcka, MD – General Surgery Resident, Emory University, @npetcka2022 Guests:  - Samuel R. Torres Landa Fernández, MD – Minimally Invasive Surgery Fellow, Emory University  - Anastasios Nikolaos (Nick​) Panagopoulos, MD – Internal Medicine Resident, Emory University  - Joe Sharma, MD - McGarity Chair in Endocrine Surgery and Professor of Surgery, Vice-chair for Patient Safety, Quality and Innovation, Emory University  Resources:  Enhancing Accuracy of Operative Reports with Automated Artificial Intelligence Analysis of Surgical Video Khanna A, Wolf T, Frank I, Krueger A, Shah P, Sharma V, Gettman MT, Boorjian SA, Asselmann D, Tollefson MK. Enhancing Accuracy of Operative Reports with Automated Artificial Intelligence Analysis of Surgical Video. J Am Coll Surg. 2025 May 1;240(5):739-746. doi: 10.1097/XCS.0000000000001352. Epub 2025 Apr 16. PMID: 39918224. https://pubmed.ncbi.nlm.nih.gov/39918224/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Improving Patient Outcomes with Innovations in Endocrine Surgery with guest Dr. Jennifer Ogilive, November 3 2024 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Thyroid lumps have always been with us. Often referred to as goitres (interpreted from Latin to mean neck swelling), numerous ancient medical sources mention these and how to manage them. However, it has only been with modern medicine and investigations that we can distinguish between benign and malignant lesions. In this episode, we examine the investigations, diagnosis, management and prognosis of thyroid lumps. This is part one of the story of Thyroid lumps. Our special guest: Dr Tiffany Symes is a histopathologist and deputy director of Anatomical Pathology at Melbourne Pathology. Associate Professor James Lee is a leading endocrine surgeon in Australia, co-editor of the Endocrine Surgery section of the ANZ Journal of Surgery and deputy co-chair of the Endocrine Surgery Section of the Royal Australasian College of Surgeons. This Medical Life podcast is available on all podcasting services and Spotify.  See omnystudio.com/listener for privacy information.

CancerNetwork® spoke with Kamran Idrees, MD, MSCI, MMHC, FACS; Natalie A. Lockney, MD; and Milad Baradaran, PhD, DABR, about the potential utility of intraoperative radiation therapy (IORT) among patients with pancreatic cancer. The group detailed the design and mechanism, gradual technical advancements, and trial data supporting the application of this radiotherapy modality for this patient population.  Idrees is the chief in the Division of Surgical Oncology & Endocrine Surgery, an associate professor of surgery, an Ingram Associate Professor of Cancer Research, and director of Pancreatic and Gastro-Intestinal Surgical Oncology at Vanderbilt University Medical Center. Lockney is an assistant professor in radiation oncology and the program director for the radiation oncology medical residency at Vanderbilt University Medical Center. Baradaran is the head of quality assurance operations and assistant professor in the Department of Radiation Oncology at Vanderbilt University Medical Center. As part of this discussion revolving around IORT, the group outlined the optimal conditions for using this technique depending on the extent of disease resectability in patients. Specifically, Idrees categorized patients as belonging to one of 3 major groups: those with metastatic disease, those with resectable disease, and those with borderline resectable or locally advanced disease. When considering these factors, patients with borderline resectable disease may be suitable to undergo IORT in combination with chemotherapy, radiotherapy, and surgery.  The conversation also focused on a particular case involving a patient with pancreatic cancer who received IORT at their institution. Based on the outcome of this case, they highlighted how multidisciplinary collaboration in combination with careful patient selection may offer surgical resection through IORT. “[There] has to be a multidisciplinary team approach to carefully select these patients and [determine] who can benefit from this procedure,” Idrees said. “For the families and the physicians who are taking care of [patients with] pancreatic cancer, it's valuable to obtain a second opinion, even if [the tumor is] initially deemed unresectable. What's unresectable in one surgeon's hands may be resectable in a different team,” he added.

Pregnancy leads to many physiologic changes, and thyroid and parathyroid disorders alter that physiology even more leading to complex laboratory interpretation and decision-making impacting both mother and fetus. In this episode, join endocrine surgeons Drs. Barb Miller, John Phay, Priya Dedhia, and Surgical Oncology Fellow Dr. Vennila Padmanaban from The Ohio State University. Hear about normal and abnormal thyroid and parathyroid physiology and treatment of patients with thyroid cancer. The group discusses several articles focusing on current guidelines from the American Thyroid Association as well as other key studies.  Hosts: Barbra S. Miller, MD (Moderator), Clinical Professor of Surgery, John Phay, MD, Clinical Professor of Surgery, Priya H. Dedhia, MD, PhD, Assistant Professor of Surgery, Vennila Padmanaban, MD, Surgical Oncology Fellow, Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio. Twitter handles:  Barbra Miller - @OSUEndosurgBSM John Phay – @JohnPhayMD Priya Dedhia – @priyaknows  Vennila Padmanaban - @vennilapadmanMD Learning objectives:  1)  Understand normal changes in thyroid and parathyroid physiology during pregnancy 2)  Describe the impact of thyroid and parathyroid dysregulation on maternal and fetal health 3)  Compare and contrast management of thyroid and parathyroid disorders during pregnancy vs. non-pregnancy   4)  Recognize the importance of multidisciplinary care of patients with thyroid and parathyroid disorders References: 1. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP, Sullivan S. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017 Mar;27(3):315-389. doi: 10.1089/thy.2016.0457. Erratum in: Thyroid. 2017 Sep;27(9):1212. doi: 10.1089/thy.2016.0457.correx. PMID: 28056690 https://pubmed.ncbi.nlm.nih.gov/28056690/ 2. Jee SB, Sawal A. Physiological Changes in Pregnant Women Due to Hormonal Changes. Cureus. 2024 Mar 5;16(3):e55544. doi: 10.7759/cureus.55544. PMID: 38576690; PMCID: PMC10993087 https://pubmed.ncbi.nlm.nih.gov/38576690/ 3. Patel, Kepal N. MD; Yip, Linwah MD; Lubitz, Carrie C. MD, MPH; Grubbs, Elizabeth G. MD; Miller, Barbra S. MD; Shen, Wen MD; Angelos, Peter MD; Chen, Herbert MD; Doherty, Gerard M. MD; Fahey, Thomas J. III MD; Kebebew, Electron MD; Livolsi, Virginia A. MD; Perrier, Nancy D. MD; Sipos, Jennifer A. MD; Sosa, Julie A. MD; Steward, David MD; Tufano, Ralph P. MD; McHenry, Christopher R. MD; Carty, Sally E. MD. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Annals of Surgery 271(3):p e21-e93, March 2020.  DOI: 10.1097/SLA.0000000000003580 https://pubmed.ncbi.nlm.nih.gov/32079830/ 4. Appelman-Dijkstra NM, Pilz S. Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy. J Clin Endocrinol Metab. 2023 May 17;108(6):1505-1513. doi: 10.1210/clinem/dgac734. PMID: 36546344; PMCID: PMC10188304 https://pubmed.ncbi.nlm.nih.gov/36546344/  5. Eremkina A, Bibik E,  Mirnaya S, Krupinova J, Gorbacheva A, Dobreva E, Mokrysheva N. Different treatment strategies in primary hyperparathyroidism during pregnancy.  Endocrine. 2022 Sep;77(3):556-560. doi: 10.1007/s12020-022-03127-3. Epub 2022 Jul 12. PMID: 35821184 https://pubmed.ncbi.nlm.nih.gov/35821184/ TRUELEARN LINK: https://truelearn.referralrock.com/l/BTKPODCAST/ Discount code: BTKPODCAST Using the discount code, you can get a discount of $25 off our Residency (General surgery, anesthesiology, OBGYN, Psychiatry, Peds, Neurology, Emergency Medicine, Internal Medicine, and Family Medicine), USMLE, andCOMLEX SmartBank subscriptions of 90-days or more. The code can also be applied for 15% off our allied healthSmartBanks (PA, Nurse Practitioner, Pharmacy, PT, OT, etc.). Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

It's that time of year (again!)- when medical students- both US and International- are preparing their residency applications. In this episode, we will focus on the special challenges International Medical Graduates face when applying to US surgical residency positions and discuss tips and tricks for making IMG residency applicants standout to program directors in the US.  Guests: David Hughes, MD- Clinical Associate Professor of Endocrine Surgery and General Surgery Residency Program Director- University of Michigan Krishnan Raghavendran, MBBS- Professor of Acute Care Surgery and Critical Care- University of Michigan Link to video:  You can watch Dr. Hughes's full presentation here: https://youtu.be/iQ0CzH7xHwE Previous DOMINATE the Match Episodes:  Episode 2- “Choose Me” (Personal Statements and Letters of Recommendations) https://behindtheknife.org/podcast/dominate-the-match-episode-2-choose-me/ Episode 3- “The Interview” https://behindtheknife.org/podcast/dominate-the-match-episode-3-the-interview/ Episode 4- “Rank and Match” https://behindtheknife.org/podcast/dominate-the-match-episode-4-rank-and-match/ Residency Program Lists:  - FREIDA Residency and Fellowship Database: https://freida.ama-assn.org/ - Doximity: https://www.doximity.com/residency/?utm_campaign=marketing_resnav_competitor_broad_20210520&utm_source=google&utm_medium=cpc&gclid=CjwKCAjwt52mBhB5EiwA05YKo1J47BLAtTPtsJBmVvXGP2pDXLLqgDIwM0pgkSYjoBhFUOO1ktXDYRoC2bkQAvD_BwE Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Making a discovery that changes how we practice is one of the most exciting things about the fields of medicine and surgery. In this episode, join endocrine surgeons Drs. Barb Miller, John Phay, Priya Dedhia, and Surgical Oncology Fellow Dr. Samantha Ruff from The Ohio State University. Hear Dr. Phay tell the story of how parathyroid autofluorescence was discovered and the work that has gone on since that day. The group discusses several articles focusing on intraoperative adjuncts used to identify parathyroid tissue during thyroid and parathyroid surgery.  Hosts: Barbra S. Miller, MD (Moderator), Clinical Professor of Surgery, John Phay, MD, Clinical Professor of Surgery, Priya H. Dedhia, MD, PhD, Assistant Professor of Surgery, Samantha Ruff, MD, Surgical Oncology Fellow, Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio. Twitter handles:  Barbra Miller - @OSUEndosurgBSM John Phay – @JohnPhayMD Priya Dedhia – @priyaknows  Samantha Ruff - @SamRuff_MD Learning objectives:  1) Understand the background of the discovery of parathyroid autofluorescence 2) Describe various intraoperative adjuncts utilized to identify parathyroid tissue 3) Compare and contrast the advantages and disadvantages of using autofluorescence versus indocyanine green for identification of parathyroid tissue   4) Recognize the impact of use of intraoperative imaging adjuncts on postoperative hypocalcemia (short and long-term) 5) Understand the general safety issues for the parathyroid imaging techniques discussed References: 1. Benmiloud, F., G. Godiris-Petit, R. Gras, et al., Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial. JAMA Surg, 2020. 155(2): p. 106-12 DOI: 10.1001/jamasurg.2019.4613. https://pubmed.ncbi.nlm.nih.gov/31693081/ 2. Kahramangil, B. and E. Berber, Comparison of indocyanine green fluorescence and parathyroid autofluorescence imaging in the identification of parathyroid glands during thyroidectomy. Gland Surg, 2017. 6(6): p. 644-8 DOI: 10.21037/gs.2017.09.04. https://pubmed.ncbi.nlm.nih.gov/29302480/ 3. Paras, C., M. Keller, L. White, et al., Near-infrared autofluorescence for the detection of parathyroid glands. J Biomed Opt, 2011. 16(6): p. 067012 DOI: 10.1117/1.3583571. https://pubmed.ncbi.nlm.nih.gov/21721833/ 4. Vidal Fortuny, J., V. Belfontali, S.M. Sadowski, et al., Parathyroid gland angiography with indocyanine green fluorescence to predict parathyroid function after thyroid surgery. Br J Surg, 2016. 103(5): p. 537-43 DOI: 10.1002/bjs.10101. https://pubmed.ncbi.nlm.nih.gov/26864909/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other Behind the Knife endocrine episodes: https://behindtheknife.org/podcast-category/endocrine/

We have a special edition of The Word on Medicine for you this Saturday. Our program discusses Keeping Your Doctors Healthy: a topic that often does not get the attention it needs. As you all know, doctors make the worst patients! In order to keep all of you healthy, we need a well-run health system and healthy doctors and nurses. Unfortunately, doctors may occasionally not take good care of themselves, something we will dive into in today's program with our special guest Dr. Carrie Cunningham, Associate Professor of Surgery at Harvard Medical School, and Section Head of Endocrine Surgery at Massachusetts General Hospital. Dr. Cunningham will be joined by our current administrative Chief Residents, Drs. Colleen Flanagan and Sam Thalji, our Residency Program Director, Dr. Rana Higgins, Dr. Dan Holena Professor of Surgery, and Dr. Alicia Pilarski, Chief Well-Being Officer at Froedtert and MCW. Please join us for this unique program as The Word on Medicine explores rarely discussed topics in health care once again.

It's that time of year (again!)- when medical students across the country are preparing their residency applications. The process can be a bit daunting, and there have been a number of changes to process for the 2024 application cycle. Join our education fellow, Dr. Jessica Millar, and Dr. David Hughes as they review the “nuts and bolts” of this year's residency application cycle.  Guests: David Hughes, MD- Clinical Associate Professor of Endocrine Surgery, General Surgery Residency Program Director- University of Michigan  Important Dates: - June 7, 2023: ERAS application opens at 9 a.m. ET. - September 6, 2023: Residency applicants may begin submitting MyERAS applications to programs at 9 a.m. ET. - September 15, 2023: Deadline to register for NRMP - September 27, 2023: Residency programs may begin reviewing MyERAS applications, MSPEs, and supplemental ERAS application data (if applicable) at 9 a.m. ET. - October 26-31, 2023: Common Interview Release Window Previous DOMINATE the Match Episodes:  Episode 2- “Choose Me” (Personal Statements and Letters of Recommendations) https://behindtheknife.org/podcast/dominate-the-match-episode-2-choose-me/ Episode 3- “The Interview” https://behindtheknife.org/podcast/dominate-the-match-episode-3-the-interview/ Episode 4- “Rank and Match” https://behindtheknife.org/podcast/dominate-the-match-episode-4-rank-and-match/ Residency Program Lists:  - FREIDA Residency and Fellowship Database: https://freida.ama-assn.org/ - Doximity: https://www.doximity.com/residency/?utm_campaign=marketing_resnav_competitor_broad_20210520&utm_source=google&utm_medium=cpc&gclid=CjwKCAjwt52mBhB5EiwA05YKo1J47BLAtTPtsJBmVvXGP2pDXLLqgDIwM0pgkSYjoBhFUOO1ktXDYRoC2bkQAvD_BwE Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our intern bootcamp series here: https://behindtheknife.org/podcast-series/medical-student-and-intern-survival-guide/

In this two-part series, we come to you LIVE! from the 2023 Annual meeting of the American Association of Endocrine Surgeons in Birmingham, Alabama. If you think evaluating and managing patients with primary hyperparathyroidism is difficult, patients with secondary and tertiary hyperparathyroidism can be even more difficult to evaluate and manage. Join Drs. Barb Miller, Sophie Dream, Jessica Liu McMullin, and Herb Chen as they break down the controversies and complexities associated with evaluation and management of these patients and discuss the recently published AAES guidelines on the definitive surgical management of patients with secondary and tertiary renal hyperparathyroidism. Part 1 focuses on the impetus for creation of these guidelines, the differences in evaluation and indication for surgery when seeing patients with renally mediated hyperparathyroidism, and preoperative planning. Part 2 focuses on intraoperative and postoperative management, parathyroid autotransplantation, and renal transplant recipients. Hosts:  - Barbra S. Miller, MD (Moderator), Clinical Professor of Surgery, The Ohio State University, @OSUEndosurgBSM - Sophie Dream, MD, Assistant Professor of Surgery, Medical College of Wisconsin, @SDreamMD, - Jessica Liu McMullin, MD, Endocrine Surgery Fellow, University of Alabama – Birmingham, @jess_mcmullin - Herbert Chen, MD, Professor and Chair of Surgery, University of Alabama – Birmingham, @herbchen Learning objectives: - Understand the epidemiology and pathogenesis of kidney-related parathyroid disease and how these entities differ from primary hyperparathyroidism - Describe the diagnosis of kidney-related hyperparathyroidism and its different presentations - Define the indications for surgical intervention - Recognize the different approaches and extents of surgery for treating the different types of renally mediated hyperparathyroidism including thymectomy and parathyroid autotransplantation - Detail methods for safe and effective perioperative management References: - Dream S, Kuo LE, Kuo JH, Sprague SM, Nwariaku FE, Wolf M, Olson JA Jr, Moe SM, Lindeman B, Chen H. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. Ann Surg. 2022 Sep 1;276(3):e141-e176. doi: 10.1097/SLA.0000000000005522. Epub 2022 Jul 18. PMID: 35848728. - Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151:959–968. - Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92:26–36. - Andress DL, Coyne DW, Kalantar-Zadeh K, et al. Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Endocr Pract. 2008;14:18–27. - Cozzolino M, Brancaccio D, Gallieni M, et al. Pathogenesis of parathyroid hyperplasia in renal failure. J Nephrol. 2005;18:5–8. - Lau WL, Cobi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018;13:952–961. - Parfrey PS, Chertow GM, Block GA, et al. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab. 2013;98:4834–4844. - Costa-Hong V, Jorgetti V, Gowdak LH, et al. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery. 2007;142:699–703. - McManus C, Oh A, Lee JA, et al. Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: a cost-effectiveness analysis. Surgery. 2021;169:94–101. - Finnerty BM, Chan TW, Jones G, et al. Parathyroidectomy versus cinacalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival. Surgery. 2019;165:129–134. Suture Kit: Purchase on suturekit.com Purchase on Amazon How-to Video Series Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out other endocrine episodes here: https://behindtheknife.org/podcast-category/endocrine/

In this two-part series, we come to you LIVE! from the 2023 Annual meeting of the American Association of Endocrine Surgeons in Birmingham, Alabama. If you think evaluating and managing patients with primary hyperparathyroidism is difficult, patients with secondary and tertiary hyperparathyroidism can be even more difficult to evaluate and manage. Join Drs. Barb Miller, Sophie Dream, Jessica Liu McMullin, and Herb Chen as they break down the controversies and complexities associated with evaluation and management of these patients and discuss the recently published AAES guidelines on the definitive surgical management of patients with secondary and tertiary renal hyperparathyroidism. Part 1 focuses on the impetus for creation of these guidelines, the differences in evaluation and indication for surgery when seeing patients with renally mediated hyperparathyroidism, and preoperative planning. Part 2 focuses on intraoperative and postoperative management, parathyroid autotransplantation, and renal transplant recipients. Hosts:  - Barbra S. Miller, MD (Moderator), Clinical Professor of Surgery, The Ohio State University, @OSUEndosurgBSM - Sophie Dream, MD, Assistant Professor of Surgery, Medical College of Wisconsin, @SDreamMD, - Jessica Liu McMullin, MD, Endocrine Surgery Fellow, University of Alabama – Birmingham, @jess_mcmullin - Herbert Chen, MD, Professor and Chair of Surgery, University of Alabama – Birmingham, @herbchen Learning objectives:  - Understand the epidemiology and pathogenesis of kidney-related parathyroid disease and how these entities differ from primary hyperparathyroidism - Describe the diagnosis of kidney-related hyperparathyroidism and its different presentations - Define the indications for surgical intervention  - Recognize the different approaches and extents of surgery for treating the different types of renally mediated hyperparathyroidism including thymectomy and parathyroid autotransplantation - Detail methods for safe and effective perioperative management References: - Dream S, Kuo LE, Kuo JH, Sprague SM, Nwariaku FE, Wolf M, Olson JA Jr, Moe SM, Lindeman B, Chen H. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. Ann Surg. 2022 Sep 1;276(3):e141-e176. doi: 10.1097/SLA.0000000000005522. Epub 2022 Jul 18. PMID: 35848728. - Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151:959–968. - Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92:26–36. - Andress DL, Coyne DW, Kalantar-Zadeh K, et al. Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Endocr Pract. 2008;14:18–27. - Cozzolino M, Brancaccio D, Gallieni M, et al. Pathogenesis of parathyroid hyperplasia in renal failure. J Nephrol. 2005;18:5–8. - Lau WL, Cobi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018;13:952–961. - Parfrey PS, Chertow GM, Block GA, et al. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab. 2013;98:4834–4844. - Costa-Hong V, Jorgetti V, Gowdak LH, et al. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery. 2007;142:699–703. - McManus C, Oh A, Lee JA, et al. Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: a cost-effectiveness analysis. Surgery. 2021;169:94–101. - Finnerty BM, Chan TW, Jones G, et al. Parathyroidectomy versus cinacalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival. Surgery. 2019;165:129–134. Suture Kit: Purchase on suturekit.com Purchase on Amazon How-to Video Series Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other endocrine episodes here: https://behindtheknife.org/podcast-category/endocrine/

In this episode the Endocrine Surgery team at BTK goes over two cases to review the American Association of Endocrine Surgeons Guidelines for Adrenalectomy.  Dr. Michael Yeh is a Professor of Surgery at UCLA and serves as Section Chief of the UCLA Endocrine Surgery program which he established.  Dr. Masha Livhits is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department Dr. James Wu is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department  Dr. Na Eun Kim is an Endocrine Surgery Fellow at UCLA in his first year of fellowship Dr. Rivfka Shenoy is a PGY-5 General Surgery Resident at UCLA who has completed two years of research  Dr. Max Schumm is a PGY-5 General Surgery Resident at UCLA who has completed two years of research. He is a future endocrine surgeon.  Important Papers  Yip L, Duh QY, Wachtel H, Jimenez C, Sturgeon C, Lee C, Velázquez-Fernández D, Berber E, Hammer GD, Bancos I, Lee JA, Marko J, Morris-Wiseman LF, Hughes MS, Livhits MJ, Han MA, Smith PW, Wilhelm S, Asa SL, Fahey TJ 3rd, McKenzie TJ, Strong VE, Perrier ND. American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. JAMA Surg. 2022 Oct 1;157(10):870-877. doi: 10.1001/jamasurg.2022.3544. PMID: 35976622; PMCID: PMC9386598. Schumm M, Hu MY, Sant V, Kim J, Tseng CH, Sanz J, Raman S, Yu R, Livhits M. Automated extraction of incidental adrenal nodules from electronic health records. Surgery. 2023 Jan;173(1):52-58. doi: 10.1016/j.surg.2022.07.028. Epub 2022 Oct 4. PMID: 36207197. M. Conall Dennedy, Anand K. Annamalai, Olivia Prankerd-Smith, Natalie Freeman, Kuhan Vengopal, Johann Graggaber, Olympia Koulouri, Andrew S. Powlson, Ashley Shaw, David J. Halsall, Mark Gurnell, Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas, The Journal of Clinical Endocrinology & Metabolism, Volume 102, Issue 3, 1 March 2017, Pages 786–792, https://doi.org/10.1210/jc.2016-2718 Amar, L., Pacak, K., Steichen, O. et al. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat Rev Endocrinol 17, 435–444 (2021). https://doi.org/10.1038/s41574-021-00492-3 **Fellowship application link: https://forms.gle/PiKM2MMQpE5jSAeW7 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other endocrine episodes here: https://behindtheknife.org/podcast-category/endocrine/

This week, Jonathan is joined by Monica Jain, Assistant Professor of Surgery, Division of Minimally Invasive, Gastrointestinal and Endocrine Surgery, and Surgical Innovation Officer at the Cedars-Sinai Health System, Beverly Hills, California, USA. They discuss the development of new healthcare innovations, human-centred design, and the role of women in biomedical engineering and technology.

In this episode of SurgOnc Today®, Dr. Julie Hallet from the University of Toronto, and Vice-Chair of the SSO HPB disease site working group, is joinded by Dr. James R. Howe from the University of Iowa and Dr. Nadine Mallak from the Oregon Health and Science University. They discuss how somatostatin receptor PET imaging, such as DOTATE-PET, can be used to guide and support the surgical management of pancreatic neuroendocrine tumors. Moderator: Julie Hallet MD, Msc; Associate Professor of Surgery. University of Toronto, Toronto, Canada; Surgical Oncologist, Susan Leslie Clinic for Neuroendocrine Tumors – Sunnybrook Health Sciences Centre, Toronto, Canada Vice-Chair, HPB DSWG, SSO Faculty:  James R. Howe, MD Professor of Surgery and Director of Surgical Oncology and Endocrine Surgery, Roy J. and Lucille A. Carver University of Iowa College of Medicine, Iowa City, Iowa Nadine Mallak, MD Associate Professor, Department of Diagnostic Radiology, Nuclear Medicine and Body Imaging sections Director, PET/MRI, Clinical, Oregon Health and Science University, Portland, OR   References NANETS guidelines for the surgical management of pancreatic neuroendocrine tumors https://nanets.net/images/guidelines/2020_NANETS_Consensus_Paper_on_the_Surgical_Management_of_Pancreatic_Neuroendocrine_Tumors.pdf   SNMMI appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors https://s3.amazonaws.com/rdcms-snmmi/files/production/public/Quality/jnm202275_New%20-%20revised.pdf

In this episode from the Endocrine Surgery team at BTK we discuss how Dr. Yeh built the section of endocrine surgery at UCLA. From Sydney, Australia to Santa Monica, he discusses the risks and challenges involved in becoming a leader in academic endocrine surgery. In this podcast we answer the question “why endocrine surgery,” and mention tips for success at all level of training from medical students to early faculty. Finally, we take a moment to honor and remember Dr. Orlo Clark.               Dr. Michael Yeh is a Professor of Surgery at UCLA and serves as Section Chief of the UCLA Endocrine Surgery program which he established.  Dr. Masha Livhits is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department  Dr. James Wu is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department  Dr. Na Eun Kim is an Endocrine Surgery Fellow at UCLA in her first year of fellowship Dr. Rivfka Shenoy is a PGY-6 General Surgery Resident at UCLA who has completed two years of research  Dr. Max Schumm is a PGY-6 General Surgery Resident at UCLA who has completed two years of research. He is a future endocrine surgeon.  Important Papers  Krishnamurthy VD, Gutnick J, Slotcavage R, Jin J, Berber E, Siperstein A, Shin JJ. Endocrine surgery fellowship graduates past, present, and future: 8 years of early job market experiences and what program directors and trainees can expect. Surgery. 2017 Jan;161(1):289-296. doi: 10.1016/j.surg.2016.06.069. Epub 2016 Nov 17. PMID: 27866719. Krishnamurthy VD, Jin J, Siperstein A, Shin JJ. Mapping endocrine surgery: Workforce analysis from the last six decades. Surgery. 2016 Jan;159(1):102-10. doi: 10.1016/j.surg.2015.08.024. Epub 2015 Oct 9. PMID: 26456130. Kulaylat AN, Kenning EM, Chesnut CH 3rd, James BC, Schubart JR, Saunders BD. The profile of successful applicants for endocrine surgery fellowships: results of a national survey. Am J Surg. 2014 Oct;208(4):685-9. doi: 10.1016/j.amjsurg.2014.03.013. Epub 2014 Jun 21. PMID: 25048570; PMCID: PMC4639920. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other Endocrine Surgery episodes here: https://behindtheknife.org/podcast-category/endocrine/

Personal Statements and Letters of Recommendations- two things that can make or break any residency or fellowship application. Join our education fellow, Dr. Jessica Millar, Dr. David Hughes, and Dr. Gifty Kwakye as they discuss what makes a truly great personal statement and how to compile a strong team for your letters of recommendation.  Guests:  David Hughes, MD- Clinical Associate Professor of Endocrine Surgery, General Surgery Residency Program Director- University of Michigan  GIfty Kwakye, MD, MPH- Clinical Assistant Professor of Colon and Rectal Surgery, Surgical Clerkship Director- University of Michigan Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our Medical Student and Intern Survival Guide here: https://behindtheknife.org/podcast-series/medical-student-and-intern-survival-guide/

It's that time of year- when medical students across the country are preparing their residency applications. The process can be a bit daunting, and there have been a number of changes to process over the past few years. Join our education fellow, Dr. Jessica Millar, and Dr. David Hughes as they review the “nuts and bolts” of this year's residency application cycle.  Guests: David Hughes, MD- Clinical Associate Professor of Endocrine Surgery, General Surgery Residency Program Director- University of Michigan  Important Dates:  ·      June 8, 2022: ERAS application opens at 9 a.m. ET. ·      August 1, 2022: Supplemental ERAS application opens for applicants. ·      September 7, 2022: Residency applicants may begin submitting ERAS applications to programs at 9 a.m. ET. ·      September 16, 2022: Supplemental ERAS application closes for applicants at 5 p.m. ET. ·      September 28, 2022: Residency programs may begin reviewing ERAS applications, MSPEs, and supplemental ERAS application data at 9 a.m. ET. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our Medical Student and Intern Survival Guide here: https://behindtheknife.org/podcast-series/medical-student-and-intern-survival-guide/

In this episode, SRGS Editor Lewis Flint, MD, FACS, talks with Rachel Kelz, MD, FACS, and Lauren Krumeich, MD, both from the University of Pennsylvania in Philadelphia, about the latest developments in the diagnosis and treatment of thyroid disease, including the use of telehealth and the effect of gastric bypass surgery on patients with thyroid issues. They also discuss innovative treatments for thyroid cancer and preoperative management of pheochromocytoma. Learn more about Selected Readings in General Surgery, an American College of Surgeons publication that highlights highly relevant and practice-changing information from the world's most prominent medical journals. #SurgicalReadings

This episode features Dr. Amy Chen. She serves as  Willard and Lillian Hackerman Professor of Otolaryngology, Vice Chair of Diversity, Equity and Inclusion, and Director of Endocrine Surgery in the Department of Otolaryngology Head and Neck Surgery at Emory University School of Medicine. 

Dr. Ismail Jatoi is chief of the Division of Surgical Oncology and Endocrine Surgery at the University of Texas Health Science Center at San Antonio. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I. Jatoi, H. Sung, and A. Jemal. The Emergence of the Racial Disparity in U.S. Breast-Cancer Mortality. N Engl J Med 2022;386:2349-2352.

In this episode from the Endocrine Surgery team at BTK we invited Dr. Kepal Patel to join us to discuss two endocrine surgery cases while discussing pertinent literature. We discuss the work-up and surgical decision making for a case of medullary thyroid cancer and a Bethesda III thyroid nodule.               Dr. Kepal Patel is the Chief of the Division of Endocrine Surgery and a Professor of Surgery, Otolaryngology and Biochemistry at NYU Langone Health. Dr. Michael Yeh is a Professor of Surgery at UCLA and serves as Section Chief of the UCLA Endocrine Surgery program which he established.  Dr. Masha Livhits is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department  Dr. James Wu is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department  Dr. Vivek Sant is an Endocrine Surgery Fellow at UCLA in his first year of fellowship Dr. Rivfka Shenoy is a PGY-5 General Surgery Resident at UCLA who has completed two years of research  Dr. Max Schumm is a PGY-5 General Surgery Resident at UCLA who has completed two years of research. He is a future endocrine surgeon.  Important Papers  Miyauchi, A., Matsuzuka, F., Hirai, K., Yokozawa, T., Kobayashi, K., Ito, Y., ... & Yamaguchi, K. (2002). Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World journal of surgery, 26(8), 1023-1028. Cibas, E. S., Baloch, Z. W., Fellegara, G., LiVolsi, V. A., Raab, S. S., Rosai, J., ... & Alexander, E. K. (2013). A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Annals of internal medicine, 159(5), 325-332. Papazian, M. R., Dublin, J. C., Patel, K. N., Oweity, T., Jacobson, A. S., Brandler, T. C., & Givi, B. (2022). Repeat Fine-Needle Aspiration With Molecular Analysis in Management of Indeterminate Thyroid Nodules. Otolaryngology–Head and Neck Surgery, 01945998221093527.   Please visit behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

This week we were joined by Dr. Pasieka once again to talk about strategies to find stress and burnout as surgeons, especially in the context of COVID19. Check out her paper below! Links: 1. Shinrin-yoku, yoga and other strategies in the fight against COVID-19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405594/ Bio: Dr. Janice L Pasieka graduated from the University of Western Medical School and did her General Surgery Training at the University of Calgary. She then did two and a half years of Endocrine Surgical Training. The first year was spent in Dr David Hanley's lab at the University of Calgary, then a year at the University of Michigan, under the mentorship of Dr. Norman Thompson followed by time at the Karolinska Institute in Stockholm, Sweden. She then returned to Calgary and has devoted her clinical practice solely to endocrine surgical diseases. At the Tom Baker Clinic Center, Dr Pasieka was the driving force behind the development of a multidisciplinary clinic for Neuroendocrine Tumors as well as the Multidisciplinary Hereditary Endocrine Clinic. She is responsible for the development of the only Canadian AAES accredited fellowship program in Endocrine Surgery. Dr Pasieka has been Secretary-Treasurer of the American Association of Endocrine Surgeons (AAES) and in 2010 she became the first Canadian and second woman to become President. She has served on the Council of the International Association of Endocrine Surgeons (IAES), and in 2016 became the Secretary-Treasurer - a position she holds at the present time. Dr Pasieka was the Canadian James IV Traveling Surgical Fellow 2006 and recently was appointed to the James VI Board of Directors. In 2007, the Women's Executive Network named her as one of Canada's 100 Most Powerful Women. Dr Pasieka recently completed her six year term as a Governor of the American College of Surgeons. Her areas of interests (besides running, mountain biking, cycling and hiking & snowshoeing with her dog Kocher) evolve around neuroendocrine tumors, adrenal disease, thyroid cancer and the study of surgical outcomes in patients with hyperparathyroidism. To date she has over 140 peer-review publications, has edited 3 Endocrine Surgical textbooks and written over 24 book chapters.

In this episode from the Endocrine Surgery team at BTK we go through three controversial topics in endocrine surgery and cite pertinent articles during a lively debate format. We debate the role of four-gland exploration versus focused exploration for parathyroid disease. Indications for parathyroidectomy are hotly contested. And finally, we discuss the role and relevance of using a nerve monitor. Tune in to see if Dr. Yeh and Dr. Wu remain collegiate after recording this episode…               Dr. Michael Yeh is a Professor of Surgery at UCLA and serves as Section Chief of the UCLA Endocrine Surgery program which he established.  Dr. Masha Livhits is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department  Dr. James Wu is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department  Dr. Vivek Sant is an Endocrine Surgery Fellow at UCLA in his first year of fellowship Dr. Rivfka Shenoy is a PGY-5 General Surgery Resident at UCLA who has completed two years of research  Dr. Max Schumm is a PGY-5 General Surgery Resident at UCLA who has completed two years of research. He is a future endocrine surgeon.  Important Papers  Norlén O, Wang KC, Tay YK, Johnson WR, Grodski S, Yeung M, Serpell J, Sidhu S, Sywak M, Delbridge L. No need to abandon focused parathyroidectomy: a multicenter study of long-term outcome after surgery for primary hyperparathyroidism. Ann Surg. 2015 May;261(5):991-6. doi: 10.1097/SLA.0000000000000715. PMID: 25565223. Schneider DF, Mazeh H, Sippel RS, Chen H. Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases. Surgery. 2012 Dec;152(6):1008-15. doi: 10.1016/j.surg.2012.08.022. Epub 2012 Oct 12. PMID: 23063313; PMCID: PMC3501613. Jinih M, O'Connell E, O'Leary DP, Liew A, Redmond HP. Focused Versus Bilateral Parathyroid Exploration for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. Ann Surg Oncol. 2017 Jul;24(7):1924-1934. doi: 10.1245/s10434-016-5694-1. Epub 2016 Nov 28. PMID: 27896505. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999 Oct 21;341(17):1249-55. doi: 10.1056/NEJM199910213411701. Erratum in: N Engl J Med 2000 Jan 13;342(2):144. PMID: 10528034. Seib CD, Meng T, Suh I, Harris AHS, Covinsky KE, Shoback DM, Trickey AW, Kebebew E, Tamura MK. Risk of Fracture Among Older Adults With Primary Hyperparathyroidism Receiving Parathyroidectomy vs Nonoperative Management. JAMA Intern Med. 2022 Jan 1;182(1):10-18. doi: 10.1001/jamainternmed.2021.6437. PMID: 34842909; PMCID: PMC8630642. Yeh MW, Zhou H, Adams AL, Ituarte PH, Li N, Liu IL, Haigh PI. The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism: An Observational Study. Ann Intern Med. 2016 Jun 7;164(11):715-23. doi: 10.7326/M15-1232. Epub 2016 Apr 5. PMID: 27043778. Zanocco K, Butt Z, Kaltman D, Elaraj D, Cella D, Holl JL, Sturgeon C. Improvement in patient-reported physical and mental health after parathyroidectomy for primary hyperparathyroidism. Surgery. 2015 Sep;158(3):837-45. doi: 10.1016/j.surg.2015.03.054. Epub 2015 May 29. PMID: 26032828. Barczyński M, Konturek A, Cichoń S. Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg. 2009 Mar;96(3):240-6. doi: 10.1002/bjs.6417. PMID: 19177420. Please visit behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

In this episode of SurgOnc Today®, David Bartlett, MD, Chair of the Allegheny Health Network Cancer Institute and SSO Past-President, is joined by Margo Shoup, MD, MBA, President of the Orlando Health Cancer Institute and Glenda Callender, MD, Medical Director of Endocrine Surgery at the Hartford HealthCare Cancer Institute. They discuss their experiences with mid-career transitions from academia to the community cancer care setting.

In this episode of The Digital Patient, Dr. Joshua Liu, Co-founder & CEO at SeamlessMD, and marketing colleague, Alan Sardana, chat with Dr. Claire E. Graves, Endocrine Surgeon at the University of California Davis, about her journey "From Arts & Humanities to Digitizing the Endocrine Surgery Journey". For show notes, please visit: https://seamless.md/blog/the-digital-patient-episode-59-dr-claire-e-graves-from-arts-humanities-to-digitizing-the-endocrine-surgery-experience

This is She's On Call, a weekly show hosted by NYC-based doctors ENT specialist Dr. Sujana Chandrasekhar and general surgeon Dr. Marina Kurian.We're talking about family medicine and endocrine surgery with Dr. Sheryl Recinos, hospitalist and author of Hindsight, and Dr. Minerva Romero Arinas, endocrine and general surgeon at NYP Brooklyn Methodist Hospital. Ask them anything! The physicians and their guests' views are their own and do not represent any institution. Please contact your doctor for any personal questions. #shesoncall

In this episode from the Endocrine Surgery team at BTK we discuss the clinical applications of genetic testing for thyroid cancer. We walk through three cases of thyroid nodules and discuss why and how genetic testing can guide surgical and medical management. As usual we review key points such as imaging criteria for thyroid nodules, the Bethesda system for thyroid cytopathology, and MEN syndromes. We also go into a more nuanced discussion of how progress in genetic testing has led to more variability in management options.               Dr. Michael Yeh is a Professor of Surgery at UCLA and serves as Section Chief of the UCLA Endocrine Surgery program which he established.  Dr. Masha Livhits is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department  Dr. James Wu is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department  Dr. Rivfka Shenoy is a PGY-5 General Surgery Resident at UCLA who has completed two years of research  Dr. Vivek Sant is an Endocrine Surgery Fellow at UCLA in his first year of fellowship Important Papers  Catherine Y Zhu, Ines Donangelo, Deepashree Gupta, Dalena T Nguyen, Joana E Ochoa, Michael W Yeh, Masha J Livhits, Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing, The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 3, March 2021, Pages e1240–e1247, https://doi.org/10.1210/clinem/dgaa887 Xing, Mingzhao & Alzahrani, Ali & Carson, Kathryn & Viola, David & Elisei, Rossella & Bendlova, Bela & Yip, Linwah & Mian, Caterina & Vianello, Federica & Tuttle, R & Robenshtok, Eyal & Fagin, James & Puxeddu, Efisio & Fugazzola, Laura & Czarniecka, Agnieszka & Jarząb, Barbara & O'Neill, Christine & Sywak, Mark & Lam, Alfred & Sykorova, Vlasta. (2013). Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer. JAMA : the journal of the American Medical Association. 309. 1493-501. 10.1001/jama.2013.3190. Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567-610. doi:10.1089/thy.2014.0335 Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid. 2019 Aug;29(8):1036-1043. doi: 10.1089/thy.2019.0133. PMID: 31319771; PMCID: PMC6707029. Please visit behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

Dr. Clancy and his guests discuss breast cancer screening from the unique perspectives of a family physician, a radiologist, and a surgeon.  Gerard Clancy, MD, Senior Associate Dean for External Affairs and Professor of Psychiatry, University of Iowa Carver College of Medicine Lillian M. Erdahl, MD, FACS, Clinical Associate Professor of Surgery-Surgical Oncology and Endocrine Surgery, University of Iowa Carver College of Medicine Erin Hayward, MD, Clinical Assistant Professor of Family Medicine, University of Iowa Carver College of Medicine Leonel A. Vasquez, MD, FACR, Clinical Associate Professor of Radiology-Division of Breast Imaging, University of Iowa Carver College of Medicine Financial Disclosures:  Dr. Gerard Clancy, guests, and the members of the planning committee for Rounding@IOWA have no relevant financial relationships to disclose. CME Credit Available:  https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=43514  Accreditation: The University of Iowa Roy J. and Lucille A. Carver College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Credit Designation: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses: Effective March 18, 2020, Iowa nurses may use participation in ACCME-accredited education toward their CE requirement for licensure. A certificate of participation will be available after successful completion of the course. (Nurses from other states should confirm with their licensing boards that this activity meets their state's licensing requirements.) Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.) Date Recorded: 9/24/2021

Every October is an opportunity for us to rise up and do more than we did the previous October and this time, it's no different. Breast cancer awareness is an effort to raise awareness and reduce the stigma of breast cancer through education on symptoms and treatment. That's exactly what we will aim to do with every episode of our podcast this month, starting with this one Welcome to another episode of What The Fifty Podcast with your host, Niki and Mich! If you're listening to this podcast for the first time, we are so glad you've joined us. Each episode features mindful conversations with speakers across all industries, focusing on how to live a more fun-filled life with less fuss. MEET DR. VINCE REID Dr. Vince Reid migrated to the USA after graduating from the Wolmers' Boys School in Kingston. He obtained his medical degree at the University of Cincinnati College of Medicine and completed his internship and residency at Maimonides Medical Center, New York where he received numerous awards including the Chief Resident of the Year Award. In later years, Dr. Reid joined the Hall-Perrine Cancer Center where he is currently the Medical Director. He also holds an appointment as Associate Professor of Surgery in the Division of Surgical Oncology & Endocrine Surgery at the University of Iowa Hospitals and Clinics. Dr. Reid's clinical practice in Surgical Oncology involves managing diseases such as Melanoma, Breast cancer, head and neck cancers and Colorectal Cancer. With over 22 years in the medical field, Dr. Reid is committed to the health and well-being of individuals. WHERE YOU CAN FIND HIM Associate Professor of Surgery: Division of Surgical Oncology and Endocrine Surgery. The University of Iowa Hospitals and Clinics Office: 319-369-4652 Fax: 319-398-6874 E-mail: vreid@mercycare.org MORE OF WHAT WE TALKED ABOUT

Dr. Juliet Lee covers what to expect with minimally invasive thyroid and parathyroid surgery.

In this episode Carmen Solorzano, MD, Chair of the SSO Endocrine Disease Site Work Group, Electron Kebebew, MD, and Geoffrey Young, MD, PhD, discuss two practice changing studies regarding the management of Medullary and Anaplastic Thyroid Cancer. Carmen Solorzano, MD, Professor of Surgery, Chair, Department of Surgery, and Director, Vanderbilt Endocrine Surgery Geoffrey Young, MD, PhD, Chief, Head and Neck Surgery; Miami Cancer Institute Electron Kebebew, MD, Professor and Chief, Stanford University School of Medicine References/Resources 1-Efficacy of Selpercatinib in RET-Altered Thyroid Cancers. Wirth LJ et al. N Engl J Med. 2020 Aug 27;383(9):825-835. doi: 10.1056/NEJMoa2005651.PMID: 32846061 2- 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer- American Thyroid Association Anaplastic Thyroid Cancer Guidelines Task Force. KC Bible, E Kebebew et al. Thyroid Published Online:12 March 2021https://doi.org/10.1089/thy.2020.0944 3-Nihilism no more: The 2021 ATA Anaplastic Thyroid Cancer Guidelines. JD Pasternak, TE Angell, J Lorch. Clinical Thyroidology Vol. 33, No.5. Published Online:7 May 2021https://doi.org/10.1089/ct.2021;33.229-234

Couldn't log on to the American Association of Endocrine Surgeons Annual Meeting this year? No need to have FOMO, in this episode from the Endocrine Surgery team at Behind the Knife, we review key abstract presentations from the meeting. We discuss the strengths and limitations of the studies, and how the results translate to clinical practice. Specifically, we go into screening and surgery for primary hyperparathyroidism after a diagnosis of nephrolithiasis, and the role of prophylactic central lymph node dissection, radioactive iodine, and radiofrequency ablation for papillary thyroid carcinoma.                    Dr. Michael Yeh is a Professor of Surgery at UCLA and serves as Section Chief of the UCLA Endocrine Surgery program which he established.    Dr. Masha Livhits is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department    Dr. James Wu is an Assistant Professor of Surgery at UCLA and works in the Endocrine Surgery Department    Dr. Rivfka Shenoy is a PGY-5 General Surgery Resident at UCLA who has completed two years of research      Important Papers    Viola, D., Materazzi, G., Valerio, L., Molinaro, E., Agate, L., Faviana, P., Seccia, V., Sensi, E., Romei, C., Piaggi, P. and Torregrossa, L., 2015. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. The Journal of Clinical Endocrinology & Metabolism, 100(4), pp.1316-1324.   Sippel, R.S., Robbins, S.E., Poehls, J.L., Pitt, S.C., Chen, H., Leverson, G., Long, K.L., Schneider, D.F. and Connor, N.P., 2020. A randomized controlled clinical trial: No clear benefit to prophylactic central neck dissection in patients with clinically node negative papillary thyroid cancer. Annals of Surgery, 272(3), pp.496-503.   Alore, E.A., Suliburk, J.W., Ramsey, D.J., Massarweh, N.N., Balentine, C.J., Singh, H., Awad, S.S. and Makris, K.I., 2019. Diagnosis and management of primary hyperparathyroidism across the Veterans Affairs health care system. JAMA internal medicine, 179(9), pp.1220-1227.   Ganesan, C., Weia, B., Thomas, I.C., Song, S., Velaer, K., Seib, C.D., Conti, S., Elliott, C., Chertow, G.M., Tamura, M.K. and Leppert, J.T., 2020. Analysis of primary hyperparathyroidism screening among US veterans with kidney stones. JAMA surgery, 155(9), pp.861-868.

Anthony Yang, MD, MS, FACS, Chair of the SSO Endocrine Disease Site Work Group is joined by fellow Workgroup Members, Mark Cohen, MD, FACS, FSSO and Cord Sturgeon, MD, MS, FACS, along with Samuel Hyde, CGC. This episode is the first of a two-part series.  The expert panel will discuss the incidence, prevalence, and epidemiology of primary hyperparathyroidism (PHPT).  They will review inherited syndromes associated with PHPT as well as when to send patients/families to genetic counseling for further evaluation and how to diagnose those syndromes.  Part two of our series will focus on the surgical management of hereditary forms of PHPT. Dr. Cohen is Professor of Surgery, Pharmacology and Biomedical Engineering; Vice Chair in Surgery for Clinical Operations; Director of the Center for Surgical Innovation; Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship; and Director of Endocrine Surgery Research at the University of Michigan. Dr. Sturgeon is Professor of Surgery, Chief of Endocrine Surgery at the Robert H. Lurie Comprehensive Cancer Center and the Director of Surgery at Northwestern Memorial Hospital.  Samuel Hyde is an ABGC-certified genetic counselor who specializes in hereditary cancer and is an instructor at the Northwestern University Feinberg School of Medicine.

Anthony Yang, MD, MS, FACS, Chair of the SSO Endocrine Disease Site Work Group is joined by fellow Workgroup Members, Mark Cohen, MD, FACS, FSSO and Cord Sturgeon, MD, MS, FACS, along with Samuel Hyde, CGC. This podcast is the second of a two-part series.  Whereas the first episode discussed an overview of primary hyperparathyroidism (PHPT) and the inherited syndromes associated with it, this episode will focus on the surgical management of hereditary forms of PHPT, specifically multiple endocrine neoplasia syndromes types 1 & 2 (MEN1 & MEN2). Dr. Cohen is Professor of Surgery, Pharmacology and Biomedical Engineering; Vice Chair in Surgery for Clinical Operations; Director of the Center for Surgical Innovation; Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship; and Director of Endocrine Surgery Research at the University of Michigan. Dr. Sturgeon is Professor of Surgery, Chief of Endocrine Surgery at the Robert H. Lurie Comprehensive Cancer Center and the Director of Surgery at Northwestern Memorial Hospital.  Samuel Hyde is an ABGC-certified genetic counselor who specializes in hereditary cancer and is an instructor at the Northwestern University Feinberg School of Medicine.

Rick Greene, MD, and Courtney Balentine, MD, discuss race and gender disparities in the time from initial diagnosis of hyperparathyroidism to treatment with parathyroidectomy. Dr. Balentine is author of, "Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons." Dr. Balentine is Assistant Professor of General and Endocrine Surgery, and Co-Director of the UTSW Surgical Center for Outcomes, Implementation and Novel Interventions (S-COIN), University of Texas Southwestern and VA North Texas Healthcare System, Dallas, TX.

It is astonishing how a pea-sized gland in one’s neck could be so troublesome. Dr. Jesse Pasternak is an endocrine surgeon at Toronto General Hospital. In this episode, we delve into the workup of hyperparathyroidism, Dr. Pasternak’s approach to parathyroid surgery, and his thoughts on the introduction of new surgical techniques. Links: 1. Charles Martell (first successful parathyroidectomy): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135504/ 2. Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma. https://pubmed.ncbi.nlm.nih.gov/31623853/ 3. David Urbach on language around thyroid nodules: https://soundcloud.com/cjs-podcast/e17-david-urbach-on-checklists-wait-times-in-the-time-of-covid-and-medical-devices/reposts 4. The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms. https://pubmed.ncbi.nlm.nih.gov/30896738/ Bio (https://surgery.utoronto.ca/faculty/jesse-pasternak): Dr Jesse Pasternak is an endocrine surgeon specializing in the surgical management of thyroid, parathyroid and adrenal tumors. After obtaining his undergraduate degree at McGill University, he completed his medical school and residency at McMaster University in Hamilton. He then moved to San Francisco, California where he trained as an Orlo Clark Fellow in Endocrine Surgery and Oncology at UCSF. Dr Pasternak also completed a master’s degree (MPH) at Harvard University with a focus in epidemiology. As a surgeon at the University Health Network, his clinical focus is minimally invasive endocrine surgery. As a researcher, he studies clinical endocrine surgery and health outcomes.

In this episode of the SeamlessMD Podcast, Dr. Joshua Liu, Co-founder & CEO at SeamlessMD, and marketing colleague, Alan Sardana, chat with Malvina Ibrahim, RD, MHSc, Patient Education Specialist at SeamlessMD on "Using Digital Patient Engagement for Endocrine Surgery". For full show notes, please visit: https://seamless.md/2020/11/24/seamlessmd-podcast-episode-24-using-digital-patient-engagement-for-endocrine-surgery/

Rick Greene, MD, and Alexandra Gangi, MD and James Howe, MD, discuss current data regarding management of neuroendocrine liver metastases and future areas for study. Dr. Gangi and Dr. Howe are authors of “The Landmark Series: Neuroendocrine Tumor Liver Metastases.” Dr. Gangi is Assistant Professor of Surgery in the Department of Surgical Oncology and the Director of the Gastrointestinal Tumor Program at Cedars-Sinai, Los Angeles, CA. Dr. James Howe is Professor of Surgery and Division Head of Surgical Oncology and Endocrine Surgery, University of Iowa Hospitals & Clinics, Iowa City, IA. Dr. Howe is also President of the North American Neuroendocrine Tumor Society and President of the Society of Surgical Oncology.

Dr. Janice L Pasieka graduated from the University of Western Medical School and did her General Surgery Training at the University of Calgary. She then did two and a half years of Endocrine Surgical Training. The first year was spent in Dr David Hanley’s lab at the University of Calgary, then a year at the University of Michigan, under the mentorship of Dr. Norman Thompson followed by time at the Karolinska Institute in Stockholm, Sweden. She then returned to Calgary and has devoted her clinical practice solely to endocrine surgical diseases. At the Tom Baker Clinic Center, Dr Pasieka was the driving force behind the development of a multidisciplinary clinic for Neuroendocrine Tumors as well as the Multidisciplinary Hereditary Endocrine Clinic. She is responsible for the development of the only Canadian AAES accredited fellowship program in Endocrine Surgery. Dr Pasieka has been Secretary-Treasurer of the American Association of Endocrine Surgeons (AAES) and in 2010 she became the first Canadian and second woman to become President. She has served on the Council of the International Association of Endocrine Surgeons (IAES), and in 2016 became the Secretary-Treasurer - a position she holds at the present time. Dr Pasieka was the Canadian James IV Traveling Surgical Fellow 2006 and recently was appointed to the James VI Board of Directors. In 2007, the Women’s Executive Network named her as one of Canada’s 100 Most Powerful Women. Dr Pasieka recently completed her six year term as a Governor of the American College of Surgeons. Her areas of interests (besides running, mountain biking, cycling and hiking & snowshoeing with her dog Kocher) evolve around neuroendocrine tumors, adrenal disease, thyroid cancer and the study of surgical outcomes in patients with hyperparathyroidism. To date she has over 140 peer-review publications, has edited 3 Endocrine Surgical textbooks and written over 24 book chapters. In this episode, we get Dr. Pasieka’s thoughts on conferences, gender equity and Dr. Pasieka’s approach to surgical education and training. Links: 1. American Association of Endocrine Surgeons (AAES): https://www.endocrinesurgery.org/ 2. Chernobyl on Netflix: https://www.imdb.com/title/tt7366338/ 3. Norm Thompson: https://americansurgical.org/transactions/Fellows/Memoirs/NormanWThompson.cgi 4. Kindred spirits of the endocrines: The training of the future endocrine surgeons. https://onlinelibrary.wiley.com/doi/abs/10.1002/jso.20176

Dr. Buck Parker, is a General & Trauma Surgeon at St. Mark's Hospital in Salt Lake City Utah. He is also a speaker, and a medical expert for the media. Dr. Parker is from Jackson Wyoming and graduated from University of Wyoming with a Bachelor of Science. He then went on to medical school in Belize at St. Matthew's University School of Medicine. He spent 6 years in General Surgery training at Henry Ford Hospital in downtown Detroit, Michigan where he had extensive training in Trauma Surgery, Transplant Surgery, Cardiac Surgery, Emergency Abdominal Surgery, Vascular Surgery, Thoracic Surgery, Plastic Surgery, Colorectal Surgery, Endocrine Surgery, Surgical Oncology as well as Surgical Intensive Care. He also did a research fellowship in a joint program with Henry Ford and NASA studying diagnostic ultrasound and remote guidance in zero gravity environments. He has published several papers on these finding together with these institutions. While in Detroit he won multiple academic awards and was awarded the “Resident Teacher of the Year” from Wayne State Medical School in 2010. He is also a self-proclaimed “tech-nerd” and entrepreneur since 2007 when he built a million-dollar web-business using internet marketing and Google search algorithms. Dr. Parker's mission now is to harness his technological and medical knowledge to drive social change, while helping individuals unlock their personal greatness. In 2015 he was a castaway and medical expert on the NBC and Bear Grylls Reality TV Series “The Island”. This show cast 14 strangers away on deserted island for 28 days with no food, water and limited supplies. The show is currently available on Hulu and Amazon. In his spare time Dr. Parker is an avid skier and enjoys exploring the mountains in all seasons. He enjoys traveling all over the world to experience different cultures. He also loves spending time with his dog “Hanky” as well as very wild and fun Italian family including his nieces and nephews who live in Jackson Hole. His biggest aspiration is to create a free medical school online for students in 3rd world countries. (Oh and he likes taking goofy pictures for his Instagram). You can check out his website by clicking here. --- Support this podcast: https://anchor.fm/ninalum/support

Dr. Todd McMullen is a scientist and endocrine surgeon at the University of Alberta in Edmonton, Alberta. In this episode we talk to Dr. McMullen about a topic that is sometimes a pain in the neck for trainees: thyroid nodules. Dr. McMullen gives us his approach to nodules, how he works them up, a brief overview of how he does his thyroidectomies, and post op calcium management. We hope you enjoy! Dr. Todd McMullen is a fellowship trained endocrine surgeon with specialized training in thyroid ultrasound techniques.He received his PhD in Biochemistry from the University of Alberta, then completed a Medical Research Council of Canada Post-Doctoral Fellowship in the Department of Physiology at the University of Virginia in Charlottesville, Virginia. Having received his PhD and additional training in Physiology, Dr. McMullen went on to complete medical school at the University of Toronto and a residency in General Surgery at the University of Alberta. He further specialized in Endocrine Surgery at the Royal North Shore Hospital in Sydney, Australia, where he finished a TS Reeve Fellowship in Endocrine Surgery. Since that time, Dr. McMullen has been an active member of the University of Alberta staff as part of the Faculty of Medicine and Dentistry, where he now holds positions in Surgery and Oncology (Division of General Surgery), an Adjunct appointment in the Division of Endocrinology (Department of Medicine) and also serves as the Director of the Division of Surgical Oncology (Department of Oncology) based at the Cross Cancer Institute. In this episode we get Dr. McMullen's approach to thyroid nodules, thyroidectomies and post-op management. Links: 1. TIRADS score: https://radiopaedia.org/articles/acr-thyroid-imaging-reporting-and-data-system-acr-ti-rads 2. South Korea's Thyroid-Cancer "Epidemic"--Turning the Tide. https://pubmed.ncbi.nlm.nih.gov/26650173/ 3. The 2017 Bethesda System for Reporting Thyroid Cytopathology. https://pubmed.ncbi.nlm.nih.gov/29091573/ 4. Minimally invasive thyroid surgery for single nodules: an evidence-based review of the lateral mini-incision technique.

An elarged thyroid glans is called a thyroid goiter, and has several causes and treatment plans.

An elarged thyroid glans is called a thyroid goiter, and has several causes and treatment plans. Stanleur Capital: Medical practice and personal financial solutions

Dr. Buck Parker, is a General & Trauma Surgeon at St. Mark's Hospital in Salt Lake City Utah. He is also a speaker, and a medical expert for the media. He sees patients with hernias, appendicitis, gallbladder disease, skin and soft tissue infections, bowel obstructions, colon disease as well as traumatic injuries. Dr. Parker is from Jackson Wyoming and graduated from University of Wyoming with a Bachelor of Science. He then went on to medical school in Belize at St. Matthew's University School of Medicine. He spent 6 years in General Surgery training at Henry Ford Hospital in downtown Detroit, Michigan where he had extensive training in Trauma Surgery, Transplant Surgery, Cardiac Surgery, Emergency Abdominal Surgery, Vascular Surgery, Thoracic Surgery, Plastic Surgery, Colorectal Surgery, Endocrine Surgery, Surgical Oncology as well as Surgical Intensive Care. He also did a research fellowship in a joint program with Henry Ford and NASA studying diagnostic ultrasound and remote guidance in zero gravity environments. He has published several papers on these finding together with these institutions. While in Detroit he won multiple academic awards and was awarded the “Resident Teacher of the Year” from Wayne State Medical School in 2010. He is also a self-proclaimed “tech-nerd” and entrepreneur since 2007 when he built a million-dollar web-business using internet marketing and Google search algorithms. Dr. Parker's mission now is to harness his technological and medical knowledge to drive social change, while helping individuals unlock their personal greatness. In 2015 he was a castaway and medical expert on the NBC and Bear Grylls Reality TV Series “The Island”. This show cast 14 strangers away on deserted island for 28 days with no food, water and limited supplies. The show is currently available on Hulu and Amazon.

This Podcast features Ritu Bhatia, Dr Pooja Ramakant, Dr Lopamudra Das Roy and Bret and Peggy Miller, who share their insights on "Reality check on preventing breast cancer and averting untimely deaths." They were keynote speakers for the Sustainable Development e-Talks (#SDGtalks) - a special series, co-hosted by CNS and Indian Institute of Management (IIM) Indore from World Health Day (7 April 2020) to World Environment Day (5 June 2020).Be welcome to listen on Apple Podcasts, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, and other podcast streaming platforms. Ritu Bhatia, senior journalist who specializes in medical and health journalism (and a breast cancer patient)Dr Pooja Ramakant, noted breast cancer surgeon and researcher; Additional Professor, Department of Endocrine Surgery, King George's Medical University (KGMU); Vice Dean of Innovations, KGMU; and former part of Editorial Board of Indian Association of Endocrine Surgeons (IAES); recipient of 2015 Fellowship of UICC (Union for International Cancer Control) in Geneva.Dr Lopamudra Das Roy, founded Breast Cancer Hub (BCH), has over 18 years of experience in research, training and mentoring UG and PhD candidates in the field of genetics and breast and pancreatic cancer. She has been a Research Professor, University of North Carolina at Charlotte. Her original research work on discovering the signaling pathway between breast cancer metastasis and arthritis, is attributed with numerous high impact factor publications and citations with global recognition from American Association of Cancer Research. She received the coveted Award of Excellence for Humanitarian service, at Male Breast Cancer Coalition Conference, 2019 Bret Miller and Peggy Miller from Male Breast Cancer Coalition (MBCC). When diagnosed with breast cancer at age 24, Bret promised his surgeon no man would ever feel alone when hearing the words, "You have breast cancer." Teaming up with others dedicated to end the stigma and feelings of abandonment associated with a male breast cancer diagnosis, Bret and his team members formed Male Breast Cancer Coalition in 2014. Breast cancer does not discriminate and we want everyone to know "Men Have Breasts Too", says MBCC team.They were in conversation with CNS Managing Editor and Executive Director Shobha Shukla, who is also the coordinator of Asia Pacific media network to end TB & tobacco, and prevent NCDs (APCAT Media). For more information, be welcome to visit www.bit.ly/sdgtalks ThanksCNS team

Dr. Juliet Lee covers what to expect with minimally invasive thyroid and parathyroid surgery.

In this episode of SurgOnc Today, Ajay Maker, MD, Director of Surgical Oncology at AIMMC/Creticos Cancer Center at the University of Illinois at Chicago, interviews SSO Gastrointestinal Disease Site Work Group members about the most influential papers in GI surgical oncology from 2019. Four conversations cover topics including: A recent Lancet study about combination chemotherapy for pancreatic cancer Advanced gastric cancer and perioperative chemotherapy regimens New therapies for metastatic gastric cancer An Annals of Surgical Oncology paper about diagnosing GI cancers from circulating tumor DNA Ajay Maker, MD, is the Director of Surgical Oncology at AIMMC/Creticos Cancer Center, and Associate Professor in the Department of Surgery, Division of Surgical Oncology at the University of Illinois at Chicago Evan S. Glazer, MD, PhD, is Assistant Professor of Surgery  and Principal Investigator, Center for Cancer Research at the University of Tennessee Health Science Center Yanghee Woo, MD, is Director, Gastroenterology Minimally Invasive Therapy Program and Associate Clinical Professor, Division of Surgical Oncology, Department of Surgery at City of Hope Mio Kitano, MD, is Assistant Professor in the Division of Surgical Oncology and Endocrine Surgery at the University of Texas Health San Antonio Carlos Chan, MD, PhD, is Assistant Professor of Surgery, Director-Molecular Epidemiology Resource Core, Assistant Professor of Radiation Oncology, Assistant Professor of Surgery, Surgical Oncology and Endocrine Surgery at the University of Iowa

SSO President-Elect, James R. Howe, MD provides various perspectives on endocrine cancers and COVID-19. Dr. Howe is the Director, Surgical Oncology and Endocrine Surgery at the Roy J. and Lucille A. Carver University of Iowa College of Medicine, Iowa City, IA.

Dr. Tobias Carling performs more adrenal gland surgeries than any other surgeon in America. In this podcast, he offers an overview of the basic functions of the adrenal system, the types of tumors and cancers in the adrenal glands as well as adrenal tumor diagnosis, and  the difficulties and goals for adrenal gland surgery as well as ways for patients to educate themselves. Dr. Tobias Carling left his position as Chief of Endocrine Surgery at Yale in 2020 to open the Carling Adrenal Center in Florida. Early in his medical schooling he found the endocrine system worthy of advanced study.  Eventually the challenges and diverse array of tumors the adrenal gland presents kept his interest and he made it his specialty. After being at Yale for almost 18 years, he started the Carling Adrenal Center in Tampa to continue giving patients exceptional care. In this podcast he begins by explaining the biology of the glands, such as the three hormones they produce: aldosterone, cortisol and catecholamines.  He explains how common it is for tumors to form in the glands and what risks they pose. Primarily, different tumors produce different degrees of hormone levels in the body in excess, which can be toxic. This, he adds, is why adrenal tumor diagnosis is important and sometimes tricky. Some cases, like Conn's Syndrome, can be a silent disease hidden by the presentation of symptoms attributed to high blood pressure. Finally, he explains various issues related to adrenal gland surgery such as when cortical-sparing surgery is advisable and when it's not. Such decisions take into account issues such as the risk of spilling tumors into the body as well as the state of the other gland. He comments that the surgery must be done as quickly as possible yet as precisely as possible because of the vital nature of the surrounding area. To learn more, see the Carling Adrenal Center Website at  https://www.adrenal.com/, which includes  a lot of information to help readers better understand everything from lab numbers to different issues to consider. They've made a concerted effort to help patients educate themselves.

Join us for our 14th joint Journal Club with Annals of Surgery! We discuss a brand-new set of guidelines from the American Association of Endocrine Surgeons to help keep us up-to-date on thyroid disease.   This episode's guest authors are Dr. Kepal Patel, the Director of Endocrine Surgery at NYU, and Dr Herb Chen, the Chair of Surgery at UAB. They are two of the authors of "Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults"   Access the executive summary free of charge here:  https://journals.lww.com/annalsofsurgery/Fulltext/2020/03000/Executive_Summary_of_the_American_Association_of.1.aspx   And the full set of guidelines here:  https://journals.lww.com/annalsofsurgery/Fulltext/2020/03000/The_American_Association_of_Endocrine_Surgeons.28.aspx

This #WorldCancerDay Podcast features a panel of experts: Thuy Khuc-Bilon from UICC; Dr Natthaya Triphuridet, lung cancer expert and post-doctoral fellow, Icahn School of Medicine at Mount Sinai, USA, and faculty, HRH Princess Chulabhorn College of Medical Science, Thailand; Dr Pooja Ramakant, breast cancer expert; Additional Professor, Department of Endocrine Surgery, King George's Medical University (KGMU) and Vice Dean, Innovation and Intellectual Property Cell, KGMU; Dr Tara Singh Bam, Deputy Regional Director (Asia Pacific), International Union Against Tuberculosis and Lung Disease (The Union) and secretariat of APCAT (Asia Pacific Cities' Alliance for Tobacco Control and NCDs Prevention); and Dr Anwar Hussain, Director, Institute of Palliative Medicine.This conversation is moderated by Shobha Shukla, founding Managing Editor, CNS; and Coordinator, APCAT Media (Asia Pacific Media Network to end TB & tobacco, and prevent NCDs); and Ashok Ramsarup, senior award-winning journalist and former Senior Producer, South African Broadcasting Corporation (SABC) Lotus FM, Durban, South AfricaThanksCNS team

Management of thyroid nodules and thyroid cancer. Guest: Thomas Fahey, MD, Chief of Endocrine Surgery, Director of the Endocrine Oncology Program and Attending Surgeon at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Host: John Leonard, MD, world-renowned hematologist and medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital.

 Dr. Rebecca Sippel discusses a whole range of endocrine pathologies in this very educational episode!  Dominate the day

M. Regina Castro, MD is a consultant in the Division of Endocrinology at the Mayo Clinic in  Rochester, MN.  She is an Associate Professor of Medicine. She is the Associate Program Director for the Endocrinology Fellowship program,  and Director of Endocrinology rotation for the  Internal Medicine Residency.  She is also a member of the Thyroid Core Group at Mayo Clinic. She served from 2009 to 2015 as Thyroid Section Editor for AACE Self-Assessment Program and has authored several chapters on Hyperthyroidism, Thyroid Nodules and thyroid cancer. She has served on various committees of the ATA, including Patient Education and Advocacy committee, the  editorial board of Clinical Thyroidology  for Patients (CTFP),  Trainees and Career Advancement committee  and  is at present  the  Chair of the Patient Affairs and Education Committee. She currently serves on the ATA Board of Directors. Her professional/academic Interests:  Clinical research related to thyroid nodules and thyroid cancer,  clinical care of patients with various thyroid diseases, and medical education. During this interview, the following topics are addressed: What is a thyroid nodule?  A lump that could be benign or cancerous The prevalence depends on how you search for them 60% of people in the U.S. will have nodules 90% are benign Sometimes done during routine physical exam Sometimes the patient discovers it Usually is discovered when imaging is done for other reasons — during CT scan Medical history of radiation to head or neck as a child, family history of thyroid cancer, size of nodule, abnormal lymph nodes in the neck Usually patients with a nodule are asymptomatic Best test to look at the nodule is an ultrasound of the nodule Features in the ultra sound determines how suspicious a nodule is A biopsy is ordered based on appearance, if nodules are clearly defined are more likely to suggest they are benign If nodule looks dark or borders are irregular, or increased blood flow within the nodule may cause concern Quality and resolution of thyroid ultra sound is high resolution and provides a clear look Coaching patients through the anxiety through a possible biopsy The majority of nodules can be observed ATA guidelines suggest observation based on the result of the biopsy Suspicious nodules that are less than 1cm are sometimes determined to best observe and not remove Cancer will be in only 5% of biopsies A smaller, low risk cancer should warrant a lesser surgery — and reduce the chance of surgical complications When to remove a nodule even if no cancer?  If other structures are being obstructed, such as breathing or swallowing, sometimes surgery relieves symptoms regardless if cancer or not Observation — and follow up recommendations 15% are labeled indeterminate If surgery, surgeon needs to be experienced — many surgeons conducting thyroid surgery are low in experience The Mayo Clinic thyroid cancer team Biopsy results in two hours versus two weeks NOTES The American Thyroid Association Dr. Regina Castro 64: Managing Indeterminate Thyroid Nodules, with Dr. Kimberly Vanderveen from Denver Center for Endocrine Surgery  

Dr. Amanda Laird, MD is an endocrine surgeon and Chief of Endocrine Surgery at the Rutgers Cancer Institute of New Jersey in New Brunswick, New Jersey. She is currently licensed to practice medicine in New Jersey and New York. She is affiliated with Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Hospital. In this interview, Dr. Laird reflects on a decade of treating papillary thyroid cancer patients and reports none have died.  In this interview we also explore these questions: Prognosis and what will happen in the long run and quality of life. Surgery complications. Levothyroxine side-effects, including weight gain.  Life after surgery and RAI. What causes thyroid cancer. What time of day to take thyroid replacement medication. What blood tests should be ordered and is fasting necessary prior to thyroid lab work. NOTES Amanda Laird, MD American Thyroid Association   

In this episode, we visit with Carla. She had thyroid cancer surgery.  During the interview, we discuss: 50 biopsies of the first nodule 5 cm nodule Biopsies RAI Weight gain Support from family NOTES American Thyroid Association 23: You Have a Thyroid Nodule, What Happens Next? with Dr. Regina Castro from The Mayo Clinic 64: Managing Indeterminate Thyroid Nodules, with Dr. Kimberly Vanderveen from Denver Center for Endocrine Surgery  

Kimberly Vanderveen, MD is a Colorado native and graduate of Bear Creek High School in Lakewood, CO. She received her bachelor’s degree with honors from Muhlenberg College in Allentown, PA. She then earned her medical degree from Northwestern University in Chicago, IL in 2001. Dr. Vanderveen completed her surgical residency at UC-Davis in Sacramento, CA. During her residency, she also obtained a master's degree in Clinical Research and was actively involved in cancer research and education. After her surgical training, Dr. Vanderveen completed a fellowship in Endocrine Surgery at the Mayo Clinic in Rochester, MN. She is knowledgeable in both medical and surgical aspects of endocrine diseases. She specializes in surgery for diseases of the thyroid, parathyroid, adrenal glands and is a high volume neck and adrenal surgeon. In this episode, the following topics are discussed: Two roads of tests: rule out and malignant markers Rule-out tests picks up innocent behavior pattern.  Most common is Afirma Malignant markers, or rule-in tests, are useful at determining extent of surgery, and help avoid a second or third surgery.  ThyroSeq, ThyraMIR, Rosetta Do patients get both tests?  Rule out and behavior? Approximately 15% of FNA’s come back indeterminate.  Some  centers as high as 30% Managing indeterminate nodules when a patient chooses no surgery. Taking into account emotional, financial, and lifestyle goals of the patient. Addressing priorities and goals of the patients should come first. Additional molecular testing, surgery, or active surveillance. Profiling a patient who choose to remove thyroid even if indeterminate — is usually due to fear and the C word. Price of molecular test is $3000 - $6000 NOTES Kimberly Vanderveen, MD American Thyroid Association PAST EPISODES 50: Regarding Thyroid Cancer, Are You a Minimalist or a Maximalist? with Dr. Michael Tuttle from Sloan Kettering 35: Rethinking Thyroid Cancer – When Saying No to Surgery Maybe Best for You with Dr. Allen Ho from Cedars-Sinai in Los Angeles 22: Avoiding Thyroid Cancer Surgery, Depending on the Size with Dr. Miyauchi from Kuma Hospital in Kobe, Japan 09: Thyroid Cancer Patients Experience Quality of Life Downgrade with Dr. Raymon Grogan and Dr. Briseis Aschebrook from the University of Chicago Medicine 08: The Financial Burden of Thyroid Cancer with Dr. Jonas de Souza from The University of Chicago Medicine  

This episode is recorded from Boston at the World Congress on Thyroid Cancer, where thyroid doctors and researchers gathered to share the latest medical research and medical improvements related to thyroid disease.  Dr. Özer Makay is an expert in nerve monitoring during thyroid surgery, and has been a guest faculty member in South Korea, Italy, France, the Netherlands, Germany, Belgium and Bulgaria.  He has received 17 awards and honors for his scientific studies.  He has authored a 300-page book on nerve monitoring during thyroid surgery.  This episode covers the following topics: Protecting the recurrent laryngeal nerve (RLN) and superior laryngeal nerve during thyroid surgery. Outcomes of damaging these nerves during surgery include no voice, hoarseness, shortness of breath, problem with drinking water or aspiration, impaired physical exertion with something as simple as climbing a flight of stairs. Why some centers have a higher occurrence of damage during thyroid surgery and include an error rate as high as 10% The cause of the damaged nerve include stretching or traction, and cutting or stitching. How to reduce risk. Is it possible to reattach a cut nerve? Surgeons who are opponents of using a nerve monitor. Pitfalls of using nerve monitoring.  Also discussed are thyroid cancer trends in Turkey including: Incidence being in the top 5 in the world. Now the number one cancer for women. Proximity to Chernobyl. Screening and awareness as a reason for the increase. 50% of population has a thyroid nodule.In the words of Dr. Özer Makay Biography:  In the words of Dr. Özer Makay I was born in 1974 in the Netherlands. After finishing the primary school there, I completed my secondary and high school educations at Bornova Anatolian High School in Izmir/Turkey. I graduated from Ege University, School of Medicine and started my residency at the General Surgery Department of Ege University, School of Medicine. During my studentship, I did my surgical internship at London King’s College Hospital. During my surgical residency, in 2002, I received education regarding “Laparoscopic Surgery” at Free University Hospital, Amsterdam from Prof. Miguel Cuesta and carried out scientific studies there. I had the opportunity to meet with the robotic surgery system here and did use this system at the experimental investigation laboratory. After being a specialist registrar in May 2005, I started to work at the division of “Endocrine Surgery” of the General Surgery Department of Ege University. During my fellowship, I worked under the supervision of Prof. Enis Yetkin, Prof. Mahir Akyıldız and Prof. Gökhan İçöz. During this period, I became the first Turkish surgeon to have the right to get the title “Fellow of European Board of Surgery – div. Endocine Surgery” by passing the “UEMS Board Examination for Endocrine Surgery”. At the Ege University, we started the “Laparoscopic Adrenalectomy Programme’ in 2008, together with Prof. Dr. Mahir Akyıldız. Besides, the “Robotic Surgery Programme’ was launched in 2012. I promoted to “Associate Professor of Surgery” in 2012. I have been invited to become a member of the European Board of Endocrine Surgery Committee. This makes me the first Turkish member of this committee. Besides, I was chosen as “the national representative” of a “European Union Health Project” concerning this area. To date, I own more than 80 national and international publications. Furthermore, I participated in more than 30 national and international scientific meetings as speaker, instructor and guest surgeon. I served as president, scientific secretary or organization/scientific committee member for national and international congresses and meetings. I had been in South Korea, Italy, France, the Netherlands, Germany, Belgium and Bulgaria as guest faculty member. I received 17 awards and honors because of my scientific studies presented during national and international scientific congresses. I speak English, Dutch and German fluently and Spanish at elementary level. My essential areas of interests are “endocrine surgery” and “robotic surgery”. As Ege University, we are the most experienced center of our country regarding “robotic adrenalectomy”. NOTES Dr. Özer Makay Contact Facebook Publications World Congress on Thyroid Cancer American Thyroid Association

Michael Singer, MD, FACS

This is an in depth discussion about the connection between flame retardants and plastics, and thyroid cancer.  These chemicals, also known as endocrine disruptors, have a clear connection to thyroid cancer occurrence. The research is presented by Julie Ann Sosa, MD MA FACS is Chief of Endocrine Surgery at Duke University and leader of the endocrine neoplasia diseases group in the Duke Cancer Institute and the Duke Clinical Research Institute. She is Professor of Surgery and Medicine. Her clinical interest is in endocrine surgery, with a focus in thyroid cancer. She is widely published in outcomes analysis, as well as cost-effectiveness analysis, meta-analysis, and survey-based research, and she is director of health services research.  NOTES: Study Associates Flame Retardants with Papillary Thyroid Cancer Flame retardants used in furniture may increase thyroid cancer risk Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 How to Buy a Sofa without Toxic Flame Retardants Julie Ann Sosa, MD

One-third of all thyroid nodule fine needle aspirations come back indeterminate. When surgery is performed on these cases, pathology of the thyroid reveals that many times the nodule is benign.  Through molecular profiling, patients with indeterminate thyroid nodules, can now avoid unnecessary surgery and get more accurate pathology results from the fine needle aspiration. Are you a patient and your doctor has said your thyroid nodule is indeterminate and is recommending surgery as an option?  The key is, to confirm that molecular profiling was performed.    Jennifer Kuo, MD is Director of the Thyroid Biopsy Program, Director of the Endocrine Surgery Research Program, and Instructor in Surgery, at the Columbia University Medical Center. Dr. Kuo received her medical degree from the College of Physicians and Surgeons at Columbia University and completed surgical training at the University of California, Davis Medical Center, in Sacramento.  Her new position follows completion of her clinical fellowship in the Department of Surgery, Division of Endocrine Surgery. Dr. Kuo has clinical expertise in minimally invasive endocrine surgery and fine-needle thyroid biopsy and is dedicated to the advancement of the field of endocrine surgery. NOTES: Dr. Jennifer Kuo Afirma - Veracyte RELATED DOCTOR THYROID EPISODES 23: You Have a Thyroid Nodule, What Happens Next? with Dr. Regina Castro from The Mayo Clinic

Mr Michael Law is a Breast and Endocrine Surgery consultant at Eastern Health. In this podcast, we talk to him about the pathway he took to end up in his role, and why that may involve spending time in other

Dr Lydia Cairncross, Head of Breast and Endocrine Surgery at Groote Schuur Hospital, speaks to #NightTalk's Lovelyn Nwadeyi about her fight for quality healthcare and accessible higher education in South Africa. 

Approximately 12 million Americans are affected by thyroid disease and some of those cases may be cancerous. When a thyroid nodule is discovered, imaging, biopsies and possibly surgery may be recommended. Jennifer Rosen, MD, Chief of Endocrine Surgery and Vice Chair of Research at MedStar Washington Hospital Center, provides the full picture of what to expect during the process.

Regenerative Medicine Today welcomes Jennifer Braemar Ogilvie, MD.  Dr. Ogilvie is an Assistant Professor in the Department of Surgery, Division of Surgical Oncology, Section of Endocrine Surgery at the University of Pittsburgh Medical Center, and a faculty member at the McGowan Institute for Regenerative Medicine. Dr. Ogilvie discusses her clinical focus on endocrine [...]